Sanofi cholesterol drug, GSK malaria shot may get EU okay Friday

LONDON (Reuters) - Sanofi and Regeneron's new cholesterol drug Praluent could be recommended for approval in Europe as early as this week, along with the world's first malaria vaccine from GlaxoSmithKline.